Medscape4d
Angiotensin Receptor Blockers and Secondary Stroke Prevention: The MOSES Study
but do angiotensin receptor blockers have the same ability? The Morbidity and Mortality after Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention (MOSES) trial endeavors to ...
Medscape3d
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in African-American Patients With Hypertension
This study was designed to assess the relative efficacy of the ACE inhibitor enalapril and the ARB candesartan cilexetil on resting BP in African-American patients with hypertension, and to ...
cryptopolitan3d
Arbitrum price prediction 2024 – 2030: ARB breaks key barrier
Our ARB predictions anticipate a high of $0.806 by the end of 2024. In 2025, it will range between $0.8875 and $1.04, with an average price of $0.9182. In 2030, it will range between $5.96 and $6.93, ...
ahajournals.org4d
Abstract 4136604: Efficacy of angiotensin receptor blockers in thoracic aortic aneurysm: meta-analysis of randomized controlled trials
Background: Thoracic aortic aneurysm (TAA) poses a significant risk of aortic dissection and mortality. Angiotensin receptor blockers (ARBs) have been proposed as a potential therapeutic intervention ...